News

FDA Amends EUA to Allow Booster Shots for Moderna, J&J COVID-19 Vaccines

October 21, 2021

In addition to allowing booster shots of the Moderna and J&J vaccines, FDA approved heterologous booster shots.

FDA Highlights Value and Challenges of Advanced Drug Manufacturing

October 21, 2021

FDA is expanding its Emerging Technology Program and providing more support for new drug applications that present advanced manufacturing technologies.

Jones Healthcare Group is Awarded EcoVadis Silver-Medal Ranking

October 21, 2021

The silver-medal ranking is given to companies who demonstrate sustainability practices that place them in the top 20% of companies rated by EcoVadis.

Aptar CSP Technologies Receives $19 Million Government Contract

October 21, 2021

The $19 million contract will expand production capacity of Aptar’s Activ-Film technology, which is used in COVID-19 testing kits.

FDA Approves Cyltezo as Interchangeable Biosimilar with Humira

October 21, 2021

Boehringer Ingelheim’s Cyltezo (adalimumab-adbm) is the first FDA approved interchangeable biosimilar for Humira.

ANGUS to Expand U.S. Manufacturing Capacity for Tromethamine Buffers

October 21, 2021

ANGUS’ planned expansion will double its tromethamine buffer production capacity.

FDA Advisory Council Unanimously Supports Johnson & Johnson COVID-19 Booster EUA

October 19, 2021

The council voted 19-0 to recommend that FDA authorize booster doses of the J&J COVID-19 vaccine just one day after granting Moderna a similar recommendation.

INTERPHEX Keynote Sessions on Wednesday, Oct. 20

October 18, 2021

The Pharmaceutical Technology and BioPharm International editors host industry experts in serialization and aseptic processing.

Evonik Launches Next-Generation Liposomal Drug Manufacturing Equipment

October 18, 2021

Evonik’s LIPEX Flow extruder is a new version of its high-pressure equipment for manufacturing liposomal drug products.

FDA Advisory Council Unanimously Supports Moderna COVID-19 Booster EUA

October 15, 2021

The council voted 19–0 to recommend that FDA authorize booster doses of the Moderna COVID-19 vaccine for certain populations.